(Q44848050)

6 December 2017

title

Augmentation of the immune response of the murine liver by levamisole (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

12 November 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

12 November 2022

author name string

J. A. Johnkoski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739174

12 November 2022

C. T. Hsueh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739174

12 November 2022

R. J. Doerr

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739174

12 November 2022

S. A. Cohen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739174

12 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

full work available at URL

6 December 2017

https://api.elsevier.com/content/article/PII:000296109290101V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

https://api.elsevier.com/content/article/PII:000296109290101V?httpAccept=text/plain

12 November 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

The American Journal of Surgery

12 November 2022

published in

1 reference

6 December 2017

volume

163

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

202-207

1 reference

The general immunopharmacology of levamisole

6 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Restoration of T-cell function in aged mice with long-term administration of levamisole

12 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

12 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer

12 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic

12 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients

12 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Effect of levamisole on the incidence of spontaneous mammary tumors in C3H mice

12 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Natural cytotoxicity of rat hepatic natural killer cells and macrophages against a syngeneic colon adenocarcinoma

12 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Natural antitumor defense system of the murine liver.

12 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Suppression of hepatic lymphokine-activated killer cell induction by murine Kupffer cells and hepatocytes

12 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Natural cytotoxicity of mouse monocytes and macrophages

12 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Stimulation of [3H]thymidine uptake in mouse marrow by granulocyte-macrophage colony stimulating factor from mouse lung conditioned medium

12 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Liver is a possible site for the proliferation of abnormal CD3+4-8- double-negative lymphocytes in autoimmune MRL-lpr/lpr mice

12 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Concentrations of levamisole required for enhanced proliferation of human lymphocytes and phagocytosis by macrophages

12 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Effects of levamisole on primary cultures of adult rat hepatocytes

12 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Toxicity of levamisole and 5-fluorouracil in human colon carcinoma cells

12 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels

12 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Immunotherapy with levamisole. Early Decrease of cAMP Levels in Lymphocytes from Treated Cancer Patients

12 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

Clinical use of recombinant human hematopoietic growth factors

12 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9610(92)90101-V

12 November 2022

Identifiers

1 reference

6 December 2017

1 reference